$46.89 +0.04 (0.09%) Novo Nordisk Shs Sponsored American DepositReceipt Repr 1 Sh -B- - New York Stock Exchange, Inc.

Aug. 26, 2016 | 04:00 PM
Last Trade: 46.89
Trade Time: Aug 26 04:00 PM Eastern Daylight Time
Change: +0.04 (0.09%)
Prev Close: 46.85
Open: 46.88
Bid: 46.82
Ask: 46.90
  1. No results found.
  1. Novo Nordisk, Weyerhaeuser Earnings, Jobs Report On Tap Friday

    Investors Business Daily | Aug. 4, 2016 | 12:26PM EST
  2. Lilly, J&J, Novo Battle For Diabetes Market Heats Up; FDA Rulings Loom

    Investors Business Daily | Jul. 22, 2016 | 10:44AM EST
  3. My Favorite Health Care Stocks

    GuruFocus | Jul. 12, 2016 | 15:26PM EST
  4. Benzinga's Top Downgrades

    Benzinga | Feb. 8, 2016 | 09:38AM EST
  5. Worst Performing Industries For February 4, 2016

    Benzinga | Feb. 4, 2016 | 11:37AM EST
  6. The 2016 Nintai Charitable Trust Portfolio: Annual Review

    GuruFocus | Jan. 18, 2016 | 15:36PM EST
  7. Novo Nordisk Files for Regulatory Approval Of Long-Acting Factor IX in EU for Treatment of Haemophilia B

    Benzinga | Jan. 7, 2016 | 05:58AM EST
  8. The 5 Top-Performing Big-Cap Drug Stocks Of 2015

    IBD | Dec. 30, 2015 | 14:16PM EST
  9. Novo Nordisk Fourth Phase 3a Trial with Semaglutide in People with Type 2 Diabetes Shows Drug Safe, Well-Tolerated

    Benzinga | Dec. 17, 2015 | 04:37AM EST
  10. Jim Simons' Top Holdings Include VeriSign, Chipotle

    GuruFocus | Dec. 15, 2015 | 17:42PM EST
  11. Novo Nordisk Submits NDA to FDA for Faster-Acting Insulin Aspart for Treatment of Type 1, 2 Diabetes

    Benzinga | Dec. 9, 2015 | 04:19AM EST
  12. Amazon, Alibaba, Facebook: A Top Mutual Fund's Bets

    IBD | Dec. 2, 2015 | 18:16PM EST
  13. Ablynx Announces Nanobody Drug Discovery Collaboration, Licence Agreement With Novo Nordisk

    Benzinga | Nov. 25, 2015 | 04:23AM EST
  14. Vestas, Novo Lead As Denmark Stocks Outpace Peers

    IBD | Nov. 19, 2015 | 17:44PM EST
  15. Value Investing in BioPharma

    GuruFocus | Nov. 18, 2015 | 13:14PM EST
Trading Center